Selecting postoperative adjuvant systemic therapy for early stage breast cancer: A critical assessment of commercially available gene expression assays.
Saved in:
| Title: | Selecting postoperative adjuvant systemic therapy for early stage breast cancer: A critical assessment of commercially available gene expression assays. |
|---|---|
| Authors: | Hyams DM; Desert Surgical Oncology, Eisenhower Medical Center, Rancho Mirage, California., Schuur E; VMWA LLC, Palo Alto, California., Angel Aristizabal J; Instituto Nacional de Cancerología, Bogota, Colombia., Bargallo Rocha JE; Instituto Nacional de Cancerología, Mexico City, Mexico., Cabello C; Universidade Estadual de Campinas, Campinas, Brazil., Elizalde R; Hospital Dr. Ignacio Pirovano, Buenos Aires, Argentina., García-Estévez L; Centro Integral Oncológico Comprensivo Clara Campal, Madrid, Spain., Gomez HL; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Katz A; Hospital Sírio-Libanes, Sao Paulo, Brazil., Nuñez De Pierro A; Hospital Dr. Juan A. Fernandez, Buenos Aires, Argentina. |
| Source: | Journal of surgical oncology [J Surg Oncol] 2017 May; Vol. 115 (6), pp. 647-662. Date of Electronic Publication: 2017 Feb 17. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0222643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9098 (Electronic) Linking ISSN: 00224790 NLM ISO Abbreviation: J Surg Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
